ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 319

Systemic Juvenile Idiopathic Arthritis and Exposure to Fine Particulate Air Pollution

Andrew S. Zeft1, Sampath Prahalad2, Rayfel Schneider3, Alexei Grom4, Fatma Dedeoglu5, Pamela F. Weiss6, Carter Mix7 and C. Arden Pope8, 1Pediatrics, Rheumatology, The Cleveland Clinic, Cleveland, OH, 2Emory University, Atlanta, GA, 3Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 4Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 5on behalf of CARRAnet Investigators, Palo Alto, CA, 6Rheumatology, The Children's Hospital of Philadelphia, Philadelphia, PA, 7Brigham Young University, Provo, UT, 8Economics, Brigham Young University, Provo, UT

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Environmental factors, environmental pathogens, epidemiologic methods and risk, Systemic JIA

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Pathogenesis and Genetics

Session Type: Abstract Submissions (ACR)

Background/Purpose: Environmental factors are understood to play a pathogenic role in the etiology of Systemic Onset Juvenile Idiopathic Arthritis (SJIA). Fine particulate matter (aerodynamic diameter £2.5-mm cut point, PM2.5) is a measurable component of ambient urban pollution, and positive associations of short-term PM2.5 exposure with the reported clinical presentation of SJIA in young children have been described in a regional cohort. Our objective was to further establish associations between short-term ambient pollution exposures and the reported clinical event dates of SJIA onset in cases residing from multiple metropolitan regions. 

Methods: A case-crossover study design was used to analyze associations of short-term PM2.5 exposures with the event date of SJIA symptom onset from cases residing in the metropolitan regions of Boston, Philadelphia, Atlanta, Cincinnati, and Toronto. Time trends, seasonality, month, and weekday were controlled for by matching. Selected exposure windows (up to 14 days) of PM2.5 were examined.

Results: Positive, statistically significant associations between PM2.5 concentrations and elevated risk of SJIA onset were not observed.  The most positive associations of short-term PM2.5 exposure with the reported clinical onset of SJIA were in children <5.5 years of age (RR 1.75, 95% CI 0.85-3.62). An ad hoc extended pooled analysis including previously reported cases residing from Utah’s metro areas identified an increased risk of SJIA for children <5.5 years of age (RR = 1.76, 95% CI 1.07-2.89 per 10 µg/m3 increase in 3-day lagged moving average of PM2.5).

Conclusion: Even in this multi-city, multi-period study only small, statistically insignificant PM2.5-SJIA associations are observed. However, similar to previously observed results, the PM2.5-SJIA association is most suggestive in preschool aged children. More subjects with spatial and temporal specificity may be required by the analysis to demonstrate effects, and further research may be useful in larger numbers of SJIA cases and in geographic areas which experience a greater ambient particulate burden.


Disclosure:

A. S. Zeft,
None;

S. Prahalad,
None;

R. Schneider,
None;

A. Grom,
None;

F. Dedeoglu,
None;

P. F. Weiss,
None;

C. Mix,
None;

C. A. Pope,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/systemic-juvenile-idiopathic-arthritis-and-exposure-to-fine-particulate-air-pollution/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology